Updates are available Correction dated 2025-09-29
Click to view Correction: https://doi.org/10.1007/s40121-025-01242-y
-
Authors
Al Musawa, Mohammed
Kunz Coyne, Ashlan J.
Alosaimy, Sara
Lucas, Kristen
Schrack, Melanie Rae
Andrade, Justin
Herbin, Shelbye R.
Biagi, Mark
Pierce, Michael
Molina, Kyle C.
DeKerlegand, Alaina
Perkins, Nicholson B. III
Cosimi, Reese
Kang-Birken, Lena
King, Madeline A.
Pullinger, Benjamin M.
Rojas, Leonor M.
Bouchard, Jeannette
Hobbs, Athena L. V.
Agee, Jazmin
Caniff, Kaylee E.
Van Helden, Sean R.
Veve, Michael P.
Rybak, Michael J. https://orcid.org/0000-0002-1094-043X
-
Funding
Funding for this research was provided by:
Innoviva Specialty Therapeutics, Inc., through its affiliate Tetraphase Pharmaceuticals.
- License Information
-
More Information
Article History
Received: 3 April 2025
Accepted: 19 May 2025
First Online: 6 June 2025
Change Date: 29 September 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s40121-025-01242-y
Declarations
:
: Michael J. Rybak declares that he has received research grant support, has spoken on behalf of or consulted for AbbVie, Innoviva, Melinta, Merck, and Shionogi. Michael J. Rybak is an Editor-in-Chief of Infectious Diseases and Therapy. Michael J. Rybak was not involved in the selection of peer reviewers for the manuscript nor any of the subsequent editorial decisions. Ashlan J. Kunz Coyne declares that she served on an advisory board for AbbVie. Kyle C. Molina declares that he serves as consultant for Melinta, Shionogi, Innoviva Specialty Therapeutics, and Merck and received grants from Melinta and Merck. Michael P. Veve declares that he has received funding from and/or consulted for Innoviva Specialty Therapeutics, Inc. Mohammed Al Musawa, Sara Alosaimy, Kristen Lucas, Melanie Rae Schrack, Justin Andrade, Shelbye R. Herbin, Mark Biagi, Michael Pierce, Nicholson B. Perkins III, Reese Cosimi, Lena Kang-Birken, Madeline A. King, Benjamin M. Pullinger, Leonor M. Rojas, Jeannette Bouchard, Tristan Gore, Athena L.V. Hobbs, Jazmin Agee, Kaylee E. Caniff, and Sean R. Van Helden declare that they have no competing interests.
: This study was conducted in accordance with the Helsinki Declaration of 1964 and its subsequent amendments. It received approval from the Wayne State University Institutional Review Board (052019MP2X), which served as the coordinating center. Additionally, it was approved by the institutional review board or ethics committee at each participating site. Since this was a retrospective study, the requirement for patient consent has been waived.
